Naturally Splendid Packaging Line Commences Operations and Warrant Exercise Raises $445,425 Mar 14, 2017
RepliCel Pursues Non-Diluting Grant Funding to Accelerate Value Creation and Commercialization Mar 8, 2017
DelMar Pharmaceuticals to Participate in Key Opinion Leader Luncheon on Glioblastoma Multiforme Featuring Dr. James Perry, MD Mar 3, 2017
RepliCel Signs Two Key Service Partnerships for Final Prototype Manufacturing and Testing of its Dermal Injector Mar 1, 2017
Resverlogix Reports Positive FDA Type B Meeting on Design Issues Relating to a Proposed Phase 2a Kidney Dialysis Trial Feb 24, 2017
HempOmega™ Infused Pro369 Hemp Protein Drink To Be Featured During the NBA All-Star Weekend Feb 18, 2017
Resverlogix Highlights Unique Properties of Apabetalone in Both a Rare Muscular Dystrophy (FSHD) and Neurodegenerative Eye Disease Feb 14, 2017
DelMar Pharmaceuticals Announces Dosing of the First Patient in Phase Two Clinical Trial of VAL-083 for MGMT-unmethylated Recurrent Glioblastoma Multiforme (GBM) Feb 14, 2017
